Travere Therapeutics (TVTX) Change in Inventory (2014 - 2026)
Travere Therapeutics' (TVTX) quarterly Change in Inventory came in at $742000.0 in Q1 2026, up 120.25% YoY from $336888.2 in Q1 2025, and up 163.04% on a QoQ basis from -$1.2 million in Q4 2025.
Travere Therapeutics (TVTX) Change in Inventory (2014 - 2026) Analysis & Trends
Travere Therapeutics (TVTX) has 13 years of Change in Inventory data on file, last reported at $742000.0 in Q1 2026.
- Quarterly Change in Inventory rose 120.25% year-over-year to $742000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$610000.0 (up 64.47% YoY) and the FY2025 annual result came in at -$5.0 million, down 233.02% from the prior year.
- Change in Inventory improved to $742000.0 in Q1 2026, from -$1.2 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $22.4 million in Q4 2023 to a low of -$3.7 million in Q1 2025.
- A 5-year average of $2.4 million and a median of $285000.0 in 2024 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2023 — Change in Inventory soared 59028.95% — and 2025, when it tumbled 512.98%.
- Tracing TVTX's Change in Inventory over 5 years: stood at -$38000.0 in 2022, then soared by 59028.95% to $22.4 million in 2023, then plunged by 98.73% to $285000.0 in 2024, then plunged by 512.98% to -$1.2 million in 2025, then soared by 163.04% to $742000.0 in 2026.
- The last three Change in Inventory figures came in at $742000.0 (Q1 2026), -$1.2 million (Q4 2025), and -$194000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Travere Therapeutics | 5.85 Bn | 5.85 Bn | 162.52 Mn | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71 Mn |
| Jun 30, 2026 | 2.71 Mn |
| Mar 31, 2026 | 742,000.00 |
| Mar 31, 2026 | 742,000.00 |
| Dec 31, 2025 | -1.18 Mn |
| Dec 31, 2025 | -1.18 Mn |
| Sep 30, 2025 | -194,000.00 |
| Sep 30, 2025 | -194,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | -3.66 Mn |
| Mar 31, 2025 | -3.66 Mn |
| Dec 31, 2024 | 285,000.00 |
| Dec 31, 2024 | 285,000.00 |
| Sep 30, 2024 | 246,000.00 |
| Sep 30, 2024 | 246,000.00 |
| Jun 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Mar 31, 2024 | 1.82 Mn |